Radiofrequency ablation of liver tumors in combination with local OK-432 injection prolongs survival and suppresses distant tumor growth in the rabbit model with intra- and extrahepatic VX2 tumors

CardioVascular and Interventional Radiology

Volumn 36, Issue 5, 2013, Pages 1383-1392

  Kageyama, Ken ^a   Yamamoto, Akira ^a   Okuma, Tomohisa ^a   Hamamoto, Shinichi ^a   Takeshita, Toru ^a   Sakai, Yukimasa ^a   Nishida, Norifumi ^a   Matsuoka, Toshiyuki ^a   Miki, Yukio ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Experiment; Liver; OK 432; Rabbit; Radiofrequency ablation; VX2 tumor

Indexed keywords

PICIBANIL; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER REGRESSION; CANCER SURVIVAL; CONTROLLED STUDY; DISTANT METASTASIS; EXPERIMENTAL RABBIT; HUMAN; HUMAN CELL; LIVER CANCER; NEEDLE ELECTRODE; NONHUMAN; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; TUMOR IMMUNITY; TUMOR LOCALIZATION; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS; CATHETER ABLATION; COMBINED MODALITY THERAPY; DISEASE MODELS, ANIMAL; EAR NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; LIVER; LIVER NEOPLASMS; PICIBANIL; RABBITS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84884674145     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-013-0650-y     Document Type: Article

References (43)

1. Tateishi R, Shiina S, Teratani T et al (2005) Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 103:1201-1209
2. Gillams AR, Lees WR (2009) Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation. Eur Radiol 19:1206-1213
3. McWilliams JP, Yamamoto S, Raman SS et al (2010) Percutaneous ablation of hepatocellular carcinoma: current status. J Vasc Interv Radiol 21:S204-S213
4. Dromi SA, Walsh MP, Herby S et al (2009) Radiofrequency ablation induces antigen-presenting cell infiltration and amplification of weak tumor-induced immunity. Radiology 251:58-66
5. Hansler J, Wissniowski TT, Schuppan D et al (2006) Activation and dramatically increased cytolytic activity of tumor specific T lymphocytes after radio-frequency ablation in patients with hepatocellular carcinoma and colorectal liver metastases. World J Gastroenterol 12:3716-3721
6. Zerbini A, Pilli M, Penna A et al (2006) Radiofrequency thermal ablation of hepatocellular carcinoma liver nodules can activate and enhance tumor-specific T-cell responses. Cancer Res 66:1139-1146
7. Baran J, Baj-Krzyworzeka M, Weglarczyk K et al (2004) Modulation of monocyte-tumour cell interactions by Mycobacterium vaccae. Cancer Immunol Immunother 53:1127-1134
8. Yamamoto A, Chervoneva I, Sullivan KL et al (2009) High-dose immunoembolization: survival benefit in patients with hepatic metastases from uveal melanoma. Radiology 252:290-298
9. Nakamoto Y, Mizukoshi E, Kitahara M et al (2011) Prolonged recurrence-free survival following OK432-stimulated dendritic cell transfer into hepatocellular carcinoma during transarterial embolization. Clin Exp Immunol 163:165-177
10. Okamoto H, Shoin S, Koshimura S et al (1967) Studies on the anticancer and streptolysin S-forming abilities of hemolytic streptococci. Jpn J Microbiol 11:323-326
11. Homma S, Sagawa Y, Komita H et al (2007) Mechanism of antitumor effect on mouse hepatocellular carcinoma by intratumoral injection of OK-432, a streptococcal preparation. Cancer Immunol Immunother 56:1265-1274
12. Koido S, Hara E, Homma S et al (2007) Streptococcal preparation OK-432 promotes fusion efficiency and enhances induction of antigen-specific CTL by fusions of dendritic cells and colorectal cancer cells. J Immunol 178:613-622
13. Hovden AO, Karlesen M, Jonsson R et al (2011) Maturation of monocyte derived dendritic cells with OK432 boosts IL-12p70 secretion and conveys strong T-cell responses. BMC Immunol 12:2
14. Nakahara S, Tsunoda T, Baba T et al (2003) Dendritic cells stimulated with a bacterial product, OK-432, efficiently induce cytotoxic T lymphocytes specific to tumor rejection peptide. Cancer Res 63:4112-4118
15. Acevedo JL, Shah RK, Brietzke SE (2008) Nonsurgical therapies for lymphangiomas: a systematic review. Otolaryngol Head Neck Surg 138:418-424
16. Shimizu J, Hayashi Y, Oda M et al (1994) Treatment of postoperative chylothorax by pleurodesis with the streptococcal preparation OK-432. Thorac Cardiovasc Surg 42:233-236
17. Olsnes C, Stavang H, Brokstad K et al (2009) Chemokines are secreted by monocytes following OK-432 (lyophilized Streptococcus pyogenes) stimulation. BMC Immunol 10:6
18. Virmani S, Harris KR, Szolc-Kowalska B et al (2008) Comparison of two different methods for inoculating VX2 tumors in rabbit livers and hind limbs. J Vasc Interv Radiol 19:931-936
19. MacMahon PJ, Kennedy AM, Murphy DT et al (2009) Modified prostate volume algorithm improves transrectal US volume estimation in men presenting for prostate brachytherapy. Radiology 250:273-280
20. Kuszyk BS, Boitnott JK, Choti MA et al (2000) Local tumor recurrence following hepatic cryoablation: radiologic-histopathologic correlation in a rabbit model. Radiology 217:477-486
21. 18F-FDG small-animal PET for monitoring the therapeutic effect of CT-guided radiofrequency ablation on implanted VX2 lung tumors in rabbits. J Nucl Med 47:1351-1358
22. Hansler J, Neureiter D, Wasserburger M et al (2004) Percutaneous US-guided radiofrequency ablation with perfused needle applicators: improved survival with the VX2 tumor model in rabbits. Radiology 230:169-174
23. Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228-247
24. Jochems C, Schlom J (2011) Tumor-infiltrating immune cells and prognosis: the potential link between conventional cancer therapy and immunity. Exp Biol Med (Maywood) 236:567-579
25. Wissniowski TT, Hansler J, Neureiter D et al (2003) Activation of tumor-specific T lymphocytes by radio-frequency ablation of the VX2 hepatoma in rabbits. Cancer Res 63:6496-6500
26. Rao P, Escudier B, de Baere T (2011) Spontaneous regression of multiple pulmonary metastases after radiofrequency ablation of a single metastasis. Cardiovasc Interv Radiol 34:424-430
27. Seki T, Wakabayashi M, Nakagawa T et al (1994) Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer 74:817-825
28. Kallio R, Sequeiros R, Surcel HM et al (2006) Early cytokine responses after percutaneous magnetic resonance imaging guided laser thermoablation of malignant liver tumors. Cytokine 34:278-283
29. den Brok MH, Sutmuller RP, van der Voort R et al (2004) In situ tumor ablation creates an antigen source for the generation of antitumor immunity. Cancer Res 64:4024-4029
30. Albert ML, Sauter B, Bhardwaj N (1998) Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392(6671):86-89
31. Shi H, Cao T, Connolly JE et al (2006) Hyperthermia enhances CTL cross-priming. J Immunol 176:2134-2141
32. Callahan MK, Wohlfert EA, Menoret A, Srivastava PK (2006) Heat shock up-regulates lmp2 and lmp7 and enhances presentation of immunoproteasome- dependent epitopes. J Immunol 177:8393-8399
33. Zhang X, Gordon JR, Xiang J (2002) Advances in dendritic cell-based vaccine of cancer. Cancer Biother Radiopharm 17:601-619
34. Crispe IN, Giannandrea M, Klein I et al (2006) Cellular and molecular mechanisms of liver tolerance. Immunol Rev 213:101-118
35. Haen SP, Gouttefangeas C, Schmidt D et al (2011) Elevated serum levels of heat shock protein 70 can be detected after radiofrequency ablation. Cell Stress Chaperones 16:495-504
36. Ito A, Shinkai M, Honda H et al (2001) Augmentation of MHC class I antigen presentation via heat shock protein expression by hyperthermia. Cancer Immunol Immunother 50:515-522
37. Chen W, Syldath U, Bellmann K et al (1999) Human 60-kDa heat-shock protein: a danger signal to the innate immune system. J Immunol 162:3212-3219
38. Singh-Jasuja H, Scherer HU, Hilf N et al (2000) The heat shock protein gp96 induces maturation of dendritic cells and down-regulation of its receptor. Eur J Immunol 30:2211-2215
39. Nakamoto Y, Mizukoshi E, Tsuji H et al (2007) Combined therapy of transcatheter hepatic arterial embolization with intratumoral dendritic cell infusion for hepatocellular carcinoma: clinical safety. Clin Exp Immunol 147:296-305
40. Johnson EE, Yamane BH, Buhtoiarov IN et al (2009) Radiofrequency ablation combined with KS-IL2 immunocytokine (EMD 273066) results in an enhanced antitumor effect against murine colon adenocarcinoma. Clin Cancer Res 15:4875-4884
41. Saito K, Araki K, Reddy N et al (2011) Enhanced local dendritic cell activity and tumor-specific immunoresponse in combined radiofrequency ablation and interleukin-2 for the treatment of human head and neck cancer in a murine orthotopic model. Head Neck 33:359-367
42. Ogita K, Taguchi T, Suita S (2006) Experimental study concerning safety dosage of OK-432 for intrauterine treatment. Asian J Surg 29:202-206
43. Jie KG, Jiang H, Sun L et al (2007) The pilot study of anti-tumor effects versus immunosuppression of Staphylococcal enterotoxin C. Cancer Biol Ther 6:1584-1591